CB Scientific, Inc. (CBSC)
USD 0.04
(-11.11%)
USD 0.04
(-11.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 300.36 Thousand USD | -1.47% |
| 2022 | 304.84 Thousand USD | -53.39% |
| 2021 | 653.97 Thousand USD | 109.72% |
| 2020 | 311.83 Thousand USD | 187.17% |
| 2019 | 108.59 Thousand USD | 201.81% |
| 2018 | 35.98 Thousand USD | -40.58% |
| 2017 | 60.55 Thousand USD | -10.48% |
| 2016 | 67.64 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 183.93 Thousand USD | -38.76% |
| 2023 Q1 | 185.86 Thousand USD | -39.03% |
| 2023 Q4 | 300.36 Thousand USD | -38.72% |
| 2023 Q3 | 490.11 Thousand USD | 205.7% |
| 2023 Q2 | 160.32 Thousand USD | -13.74% |
| 2023 FY | 300.36 Thousand USD | -1.47% |
| 2022 Q3 | 172.84 Thousand USD | -39.79% |
| 2022 Q1 | 253.51 Thousand USD | -61.24% |
| 2022 FY | 304.84 Thousand USD | -53.39% |
| 2022 Q4 | 304.84 Thousand USD | 76.37% |
| 2022 Q2 | 287.05 Thousand USD | 13.23% |
| 2021 Q3 | 2.11 Million USD | 14.92% |
| 2021 FY | 653.97 Thousand USD | 109.72% |
| 2021 Q2 | 1.83 Million USD | 7.33% |
| 2021 Q1 | 1.71 Million USD | 1.3% |
| 2021 Q4 | 653.97 Thousand USD | -69.03% |
| 2020 Q4 | 1.68 Million USD | 0.0% |
| 2020 FY | 311.83 Thousand USD | 187.17% |
| 2019 FY | 108.59 Thousand USD | 201.81% |
| 2018 FY | 35.98 Thousand USD | -40.58% |
| 2017 Q4 | 60.56 USD | 0.0% |
| 2017 FY | 60.55 Thousand USD | -10.48% |
| 2016 FY | 67.64 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 83.659% |
| Ansell Limited | 3.23 Billion USD | 99.991% |
| Ansell Limited | 3.24 Billion USD | 99.991% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.939% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| Psykey, Inc. | 1.72 Million USD | 82.611% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.992% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.992% |
| Encision Inc. | 3.81 Million USD | 92.118% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | 53.924% |
| LifePoint, Inc. | 8.8 Million USD | 96.59% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 98.118% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | 66.44% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 94.528% |
| Reflect Scientific, Inc. | 2.66 Million USD | 88.746% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.95% |
| Sector 10, Inc. | 1000.00 USD | -29936.2% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.994% |
| SheerVision, Inc. | 837.56 Thousand USD | 64.139% |
| United Health Products, Inc. | 284.64 Thousand USD | -5.522% |
| Vasamed, Inc. | 1.6 Million USD | 81.23% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -34.587% |
| Yubo International Biotech Limited | 2.34 Million USD | 87.211% |